2427 — Guanze Medical Information Industry (Holding) Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
HK$722.00m
Enterprise Value
HK$672.96m
Revenue
CNY156.07m

Annual income statement for Guanze Medical Information Industry (Holding) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	141	184	211	177	156
Cost of Revenue
Gross Profit	46.4	61.6	75.7	81	85.4
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses	111	145	177	146	117
Operating Profit	29.6	39.8	33.7	31	39.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29.6	39	33.1	30	38.6
Provision for Income Taxes
Net Income After Taxes	22.3	29	23.1	18.3	27.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	22.3	29	22.9	17.9	27.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22.3	29	22.9	17.9	27.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.024	0.031	0.031	0.031	0.029
Dividends per Share